The Dechert Antitrust Merger Investigation Timing Tracker (DAMITT) is a quarterly release from Dechert LLP reporting on trends in significant merger control investigations in the United States (U.S.) and European Union...more
10/29/2020
/ Acquisitions ,
Antitrust Provisions ,
Department of Justice (DOJ) ,
EU ,
EU Merger Directive ,
European Commission ,
Federal Trade Commission (FTC) ,
Hart-Scott-Rodino Act ,
Joe Biden ,
Merger Controls ,
Mergers ,
Trump Administration ,
UK Brexit ,
UK Competition and Markets Authority (CMA) ,
United States
Fast Facts -
United States -
- The DOJ and FTC concluded 26 significant U.S. merger investigations in 2019 – similar to the level of activity from 2011-2014 under the Obama administration but trailing the activity...more
2/1/2020
/ Antitrust Investigations ,
Antitrust Litigation ,
Blocked Mergers ,
Department of Justice (DOJ) ,
EU ,
European Commission ,
European Merger Control Regulation ,
Federal Trade Commission (FTC) ,
Hart-Scott-Rodino Act ,
Merger Controls ,
Merger Remedies ,
Merger Reviews ,
Mergers ,
Phase II ,
Technology Sector ,
Trump Administration ,
UK ,
UK Brexit ,
UK Competition and Markets Authority (CMA) ,
United States
The UK may leave the EU on 29 March 2019 without a transition period or agreed arrangements on the terms of its exit. There are multiple implications:
- Businesses subject to an ongoing EU antitrust investigation on the...more
3/7/2019
/ Abuse of Dominance ,
Anticompetitive Behavior ,
Antitrust Investigations ,
EU ,
European Commission ,
Member State ,
Mergers ,
No-Deal Brexit ,
Parallel Proceedings ,
Transitional Arrangements ,
Treaty on the Functioning of the European Union (TFEU) ,
UK ,
UK Brexit ,
UK Competition and Markets Authority (CMA) ,
Withdrawal Agreement
The UK may leave the EU on 29 March 2019 without a transition period or agreed arrangements on the terms of its exit. For deals that have been notified to the European Commission but are still pending approval on 29 March,...more
2/25/2019
/ Acquisitions ,
EU ,
EU Merger Directive ,
European Commission ,
Exclusive Jurisdiction ,
Member State ,
Mergers ,
No-Deal Brexit ,
One-Stop Shop ,
Parallel Proceedings ,
Transitional Arrangements ,
UK Brexit ,
UK Competition and Markets Authority (CMA) ,
Withdrawal Agreement
The UK Competition and Markets Authority (“CMA”) recently published its infringement decision of 7 December 2016 that imposed a fine on Pfizer and Flynn Pharma (“Flynn”) for abusing their respective dominant positions by...more
9/22/2017
/ Abuse of Dominance ,
Antitrust Investigations ,
Appeals ,
Cancer ,
Drug Pricing ,
Excessive Pricing ,
Fines ,
Infringement ,
Medicines and Healthcare Products Regulatory Agency (MHRA) ,
National Health Service Corp (NHSC) ,
Pfizer ,
Pharmaceutical Industry ,
Prescription Drugs ,
UK ,
UK Competition and Markets Authority (CMA)